According to the agency, Roche has awarded Ruder Finn with a corporate positioning retainer.
A Ruder Finn spokeswoman noted that Roche’s account joins other key wins this year, which include Astellas Pharma, AstraZeneca, Mead Johnson, Merck Sharp & Dohme, Wyeth, Sandoz and Schering Plough Pharmaceuticals.
According to the agency, the projects include media training, product communication and event management and are managed out of Ruder Finn’s Shanghai, Beijing and Guangzhou offices.
A Ruder Finn spokeswoman noted that Roche’s account joins other key wins this year, which include Astellas Pharma, AstraZeneca, Mead Johnson, Merck Sharp & Dohme, Wyeth, Sandoz and Schering Plough Pharmaceuticals.
According to the agency, the projects include media training, product communication and event management and are managed out of Ruder Finn’s Shanghai, Beijing and Guangzhou offices.
.png&h=334&w=500&q=100&v=20170226&c=1)
.png&h=334&w=500&q=100&v=20170226&c=1)
.png&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=268&w=401&q=100&v=20170226&c=1)
.jpg&h=268&w=401&q=100&v=20170226&c=1)
.png&h=268&w=401&q=100&v=20170226&c=1)
